CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in United States

18 open trials have a site in United States. Registry data; only the trial team decides who can take part.

NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Augusta University, Augusta · Austin Neuromuscular Center, Austin · Johns Hopkins Hospital, Baltimore · Boston Clinical Trials, Boston · IMMUNOe Health and Research Centers, Centennial · The Neurological Institute PA, Charlotte · Cleveland Clinic - Main Campus, Cleveland · Healthcare Innovations Institute Inc, Coral Springs · University of Kansas Medical Center, Kansas City · Kansas City Veterans Affairs Medical Center, Kansas City · Neurology Associates PA, Maitland · ALS Center at the University of Miami, Miami · Advocate Health - Aurora St. Luke's Medical Center, Milwaukee · The Neurological Institute of New York, New York · South Shore Neurologic Associates - Patchogue, Patchogue · Beaumont Hospital, Royal Oak, Royal Oak
Registry updated 2026-11-03
NCT06920004
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Trial Treatment · Phase 3 · argenx
University of Michigan Hospital, Ann Arbor · University of Alabama, Birmingham · University of Cincinnati Health, Cincinnati · Colorado Springs Neurological Associates, Colorado Springs · Erlanger Health System, Columbia · Homestead Associates in Research Inc, Homestead · NeuroCarePlus, Houston · National Neuromuscular Research Institute, Irving · University Neurology, Knoxville · Visionary Investigators Network, Miami · Baptist Health Medical Group Neurology, Nicholasville · Perelman Center for Advanced Medicine, Philadelphia · Jefferson Health Honickman Center, Philadelphia · Samir Macwan, M.D., Inc., Rancho Mirage · Paradigm Health System, Slidell · University of South Florida, Tampa · Banner University of Arizona Medical Center, Tucson · MedStar Washington Hospital Center, Washington D.C.
Registry updated 2026-11-03
NCT07264426
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Research · argenx
PPD Virtual, Wilmington
Registry updated 2026-11-03
NCT06858579
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Trial Treatment · Phase 3 · Dianthus Therapeutics
Clinical Study Site, Birmingham · Clinical Study Site, Burlington · Clinical Study Site, Chicago · Clinical Study Site, Cincinnati · Clinical Study Site, Columbus · Clinical Study Site, Dallas · Clinical Study Site, Denton · Clinical Study Site, East Lansing · Clinical Study Site, Edwardsville · Clinical Study Site, Honolulu · Texas Locations, Houston · Cinical Study Site, Houston · Clinical Study Site, Indianapolis · Clinical Study Site, Kansas City · Cinical Study Site, Lebanon · Clinical Study Site, Los Angeles · Clinical Study Site, Maitland · Cinical Study Site, Nashville · Cinical Study Site, New Haven · Clinical Study Site, New York · Clinical Study Site, Omaha · Clinical Study Site, Phoenix · Clinical Study Site, Portland · Clinical Study Site, Round Rock · Clinical Study Site, San Francisco · Clinical Study Site, Scottsdale · Clinical Study Site, Seattle · Clinical Study Site, Sugar Land · Clinical Study Site, Tampa · Clinical Study Site, Washington D.C.
Registry updated 2026-10-28
NCT06680037
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Trial Treatment · Phase 1 · TG Therapeutics, Inc.
TG Therapeutics Investigational Trial Site, Ann Arbor · TG Therapeutics Investigational Trial Site, Cleveland · TG Therapeutics Investigational Trial Site, Columbus · TG Therapeutics Investigational Trial Site, La Jolla · TG Therapeutics Investigational Trial Site, Milwaukee · TG Therapeutics Investigational Trial Site, New York · TG Therapeutics Investigational Trial Site, Omaha · TG Therapeutics Investigational Trial Site, Rochester
Registry updated 2026-10-27
NCT06859099
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Trial Treatment · Phase 3 · Sanofi
Alabama Neurology Associates- Site Number : 8400019, Homewood · University of Kansas Medical Center- Site Number : 8400010, Kansas City · Columbia University Irving Medical Center- Site Number : 8400003, New York · Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia · Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014, Scottsdale
Registry updated 2026-10-27
NCT07091630
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Trial Treatment · Phase 3 · argenx
National Neuromuscular Research Institute, Austin · University of Alabama at Birmingham - 1720 University Blvd, Birmingham · Colorado Springs Neurological Associates, Colorado Springs · NeuroCarePlus, Houston · University Neurology, Knoxville · Gables Neurology, Miami · Aqualane Clinical Research, Naples · Penn Medicine University City, Philadelphia · Jefferson Health Honickman Center, Philadelphia · Samir Macwan, M.D., Inc. (S corporation), Rancho Mirage · Paradigm Health System, Slidell · Vero Beach Neurology and Research Institute, Vero Beach · Medstar Health Research Institute, Washington D.C.
Registry updated 2026-10-27
NCT06290141
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 3 · Sanofi
Dent Neurologic Institute - Amherst- Site Number : 8400039, Amherst · Austin Neuromuscular Center- Site Number : 8400040, Austin · Wilmer Instit John Hopkins Hosp Univ Sch Medicine- Site Number : 8400015, Baltimore · Gadolin Research - Beaumont- Site Number : 8400047, Beaumont · Massachusetts General Hospital-Genetics- Site Number : 8400009, Boston · DM Clinical Research - Bradenton- Site Number : 8400044, Bradenton · University of Vermont Medical Center- Site Number : 8400012, Burlington · IMMUNOe International Research Centers - Centennial- Site Number : 8400049, Centennial · University of Virginia- Site Number : 8400023, Charlottesville · University of Cincinnati Medical Center- Site Number : 8400020, Cincinnati · University Hospitals Cleveland Medical Center- Site Number : 8400033, Cleveland · Henry Ford Hospital- Site Number : 8400025, Detroit · Michigan State University- Site Number : 8400038, East Lansing · Yale University School Of Medicine Department Of Neurology- Site Number : 8400018, Fairfield · Endeavor Health - NorthShore Kellogg Cancer Center - Glenbrook- Site Number : 8400024, Glenview · Penn State Health Milton South Hershey Medical Center- Site Number : 8400042, Hershey · Alabama Neurology Associates- Site Number : 8400019, Homewood · Uthealth - The University Of Texas Health Sciences Center At Houston- Site Number : 8400050, Houston · University of Kansas Medical Center- Site Number : 8400010, Kansas City · Northwell Health Physician Partners Dermatology at Lake Success- Site Number : 8400051, Lake Success · Profound Research- Site Number : 8400052, Las Vegas · University Of Southern California- Site Number : 8400002, Los Angeles · Research by Design, LLC- Site Number : 8400053, Miami Lakes · Ochsner Medical Center - Jefferson Highway- Site Number : 8400030, New Orleans · Columbia University Irving Medical Center- Site Number : 8400003, New York · Hospital for Special Surgery - Site Number : 8400041, New York · University of California Irvine - Manchester Pavilion- Site Number : 8400007, Orange · AdventHealth Orlando- Site Number : 8400006, Orlando · Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022, Philadelphia · Raleigh Neurology Associates- Site Number : 8400043, Raleigh · HonorHealth Bob Bove Neuroscience Institute - Site Number : 8400014, Scottsdale · Washington University School of Medicine- Site Number : 8400037, St Louis
Registry updated 2026-10-19
NCT07304154
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
Trial Treatment · Phase 1 · Kite, A Gilead Company
Hoag Memorial Hospital Presbyterian, Newport Beach · Columbia University Irving Medical Center, New York · Stanford Neuroscience Health Center, Palo Alto · LDS Hospital - Intermountain Health, Salt Lake City · Fred Hutchinson Cancer Center, Seattle
Registry updated 2026-10-19
NCT07540221
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Trial Treatment · Phase 3 · Grifols Therapeutics LLC
GC2402 Study Site 109, Coral Springs · GC2402 Study Site 111, Cordova · GC2402 Study Site 114, Fayetteville · GC2402 Study Site 115, Houston · GC2402 Study Site 105, Miami · GC2402 Study Site 110, New York · GC2402 Study Site 103, Port Charlotte · GC2402 Study Site 104, Rancho Mirage · GC2402 Study Site 106, Sherman
Registry updated 2026-10-09
NCT07032662
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 2 · Immunovant Sciences GmbH
Site Number - 1623, Boston · Site Number - 1624, Canton · Site Number - 1618, Carlsbad · Site Number - 1635, Chapel Hill · Site Number - 1610, Charlotte · Site Number - 1632, Chicago · Site Number - 1629, Detroit · Site Number - 1622, Houston · Site Number - 1602, Kansas City · Site Number - 1634, Las Vegas · Site Number - 1603, Maitland · Site Number - 1606, Miami · Site Number - 1613, Milwaukee · Site Number - 1637, Mission Hills · Site Number - 1621, New Haven · Site Number - 1627, New York · Site Number - 1605, New York · Site Number - 1611, Nicholasville · Site Number - 1619, Orange · Site Number - 1617, Ormond Beach · Site Number - 1626, Parker · Site Number - 1616, Philadelphia · Site Number - 1620, Port Charlotte · Site Number - 1614, Portland · Site Number - 1607, Rancho Mirage · Site Number - 1633, Rockledge · Site Number - 1628, San Antonio · Site Number -1608, San Francisco · Site Number - 1612, Tucson · Site Number - 1601, Washington D.C. · Site Number - 1630, Washington D.C. · Site Number - 1625, Worcester · Site Number - 1631, Yukon
Registry updated 2026-09-30
NCT06752356
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Trial Treatment · Phase 3 · Kedrion S.p.A.
Advanced Neurology Epilepsy and Sleep Center/ANESC Research, El Paso · Dartmouth Hitchcock Medical Center, Lebanon · Quantix Research, Miami · New England Institute for Clinical Research, Stamford · USF Health Morsani Center for Advanced Healthcare, Tampa
Registry updated 2026-09-11
NCT04929236
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Trial Treatment · Phase 3 · Octapharma
Octapharma Research Site, Birmingham · Octapharma Research Site, Charlottesville · Octapharma Research Site, Houston · Octapharma Research Site, Louisville · Octapharma Research Site, Orange · Octapharma Research Site, Philadelphia
Registry updated 2026-08-05
NCT06968975
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Research · Sanofi
Investigational Site, Swiftwater
Registry updated 2026-07-24
NCT03684018
Two Dose Levels of Privigen in Pediatric CIDP
Trial Treatment · Phase 4 · CSL Behring
Akron Children's Hospital, Akron · Neurology Rare Disease Center, Flower Mound · University of Iowa Hospitals and Clinics, Iowa City · Children's Hospital of Los Angeles, Los Angeles · Le Bonheur Children's Hospital, Memphis · Children's Specialty Group, Norfolk · Children's Hospital of Philadelphia, Philadelphia · Phoenix Children s Hospital, Phoenix · Seattle Children's Hospital, Seattle
Registry updated 2026-06-01
NCT07478172
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Trial Treatment · University of Missouri-Columbia
NextGen Precision Health Building, Clinical and Translational Science Unit, Columbia
Registry updated 2026-03-17
NCT06299748
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Research · argenx
United BioSource LLC, Morgantown
Registry updated 2026-02-17
NCT05584631
IVIG vs SCIG in CIDP
Trial Treatment · Phase 1 · Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey Clinical Research Center, New Brunswick
Registry updated 2025-12-11

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error